Back to Results
First PageMeta Content
Pharmaceutical sciences / Clinical research / Pharmaceutical industry / Pharmacology / Drug safety / Health Canada / Health Products and Food Branch / Food and Drugs Act / Regulatory requirement / Medicine / Health / Pharmaceuticals policy


Guidance Policy - Use of Positron Emitting Radiopharmaceuticals (PERs) in Basic Research Policy (POL-0053)
Add to Reading List

Document Date: 2013-07-09 10:25:50

Open Document

File Size: 112,32 KB

Share Result on Facebook

City

Ottawa / /

Country

Canada / /

/

Event

Product Issues / /

Facility

Food Branch Inspectorate Graham Spry Building / /

/

IndustryTerm

natural health products / related biotechnology products / drug products / hazardous products / food / clinical trial applications / /

MedicalCondition

disease / /

Organization

Drug GMP Inspection Unit / Health Products and Food Branch / Policy Statement Division / Biologics and Genetic Therapies Directorate / /

Person

Diana Dowthwaite / /

/

Position

Director / /

Product

products / /

ProgrammingLanguage

C / /

ProvinceOrState

Ontario / /

Technology

radiopharmaceuticals / pharmacokinetics / Tomography / biotechnology / /

URL

http /

SocialTag